Breaking: FDA Relabels Leucovorin, Paving Way for Autism Treatment
Breaking: FDA Relabels Leucovorin, Paving Way for Autism Treatment In a significant announcement yesterday, Dr. Marty Makary, Commissioner of the Food and Drug Administration (FDA), revealed that the agency is modifying the label of leucovorin, an often-overlooked medicine. This crucial change will allow leucovorin to be made available for children with autism. Leucovorin, also known as folinic acid, is a modified version of vitamin B9 (folate), a nutrient naturally present in foods like beans, leafy greens, eggs, and citrus. Folate…